PMC:7696151 / 9757-10049
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 233 | 46-51 | Gene | denotes | gp120 | Gene:3700 |
| 309 | 212-217 | Species | denotes | HIV-1 | Tax:11676 |
| 312 | 230-233 | Chemical | denotes | HCQ | MESH:D006886 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T82 | 4-126 | Sentence | denotes | Consequently, there was a modification of gp120 immunogenic properties and a reduction of new virions infectivity [15,16]. |
| T83 | 127-256 | Sentence | denotes | The first randomized, double-blind, placebo-controlled clinical trial about the anti-HIV-1 activity of HCQ was published in 1995. |